Lemke K A, Tranquilli W J, Thurmon J C, Benson G J, Olson W A
Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana.
Vet Surg. 1994 Jan-Feb;23(1):61-6. doi: 10.1111/j.1532-950x.1994.tb00446.x.
The arrhythmogenic effects of anesthetic drugs are assessed using the arrhythmogenic dose of epinephrine (ADE) model. The purpose of this study was to determine the influence of cholinergic blockade (CB) produced by glycopyrrolate (G) on ADE in 1.5 minimum alveolar concentration (MAC) halothane (H)- and isoflurane (I)-anesthetized dogs. Eight dogs (weighing between 12.5 and 21.5 kg) were randomly assigned to four treatment groups (H, HG, I, and IG) and each treatment was replicated three times. Anesthesia was induced and maintained with H (1.31%, end-tidal [ET]) or I (1.95%, ET) in oxygen. Ventilation was controlled (carbon dioxide [PCO2] 35 to 40 mmHg, ET). G was administered 10 minutes before ADE determination at a dose of 22 microgram/kg (11 microgram/kg, intravenous [IV] and 11 micrograms/kg, intramuscular [IM]). The ADE was determined by IV infusion of epinephrine at sequentially increasing rates of 1.0, 2.5, and 5.0 micrograms/kg/min; and defined as the total dose of epinephrine producing at least four ectopic ventricular contractions (EVCs) within 15 seconds during a 3-minute infusion and up to 1 minute after the end of the infusion. Total dose was calculated as the product of infusion rate and time to arrhythmia. Data were analyzed using a randomized complete block analysis of variance. When significant (P < .05) F values were found a least significant difference test was used to compare group means. Values are reported as means +/- standard error. The ADE (micrograms/kg) for H, HG, I, and IG were 1.53 +/- 0.08, 3.37 +/- 0.46, 1.61 +/- 0.21, and > 15.00, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
使用肾上腺素致心律失常剂量(ADE)模型评估麻醉药物的致心律失常作用。本研究的目的是确定在1.5倍最低肺泡浓度(MAC)的氟烷(H)和异氟烷(I)麻醉的犬中,格隆溴铵(G)产生的胆碱能阻滞(CB)对ADE的影响。将8只犬(体重在12.5至21.5千克之间)随机分为四个治疗组(H、HG、I和IG),每个治疗重复三次。用H(1.31%,呼气末[ET])或I(1.95%,ET)在氧气中诱导并维持麻醉。控制通气(二氧化碳[PCO2] 35至40 mmHg,ET)。在测定ADE前10分钟,以22微克/千克的剂量(11微克/千克,静脉注射[IV]和11微克/千克,肌肉注射[IM])给予G。通过以1.0、2.5和5.0微克/千克/分钟的递增速率静脉输注肾上腺素来确定ADE;定义为在3分钟输注期间及输注结束后1分钟内15秒内产生至少4次室性异位收缩(EVC)的肾上腺素总剂量。总剂量计算为输注速率与心律失常时间的乘积。使用随机完全区组方差分析对数据进行分析。当发现显著(P <.05)F值时,使用最小显著差异检验比较组均值。数值报告为均值±标准误差。H、HG、I和IG的ADE(微克/千克)分别为1.53±0.08、3.37±0.46、1.61±0.21和> 15.00。(摘要截断于250字)